JP Morgan Chase
AGN

JP Morgan Chase’s Allergan plc AGN Stock Holding History

JP Morgan Chase’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3,705,099
Closed -$656M – 5934
2020
Q1 		$656M Buy
3,705,099
+956,164
+35% +$180M 0.15% 143
2019
Q4 		$526M Sell
2,748,935
-2,849,421
-51% -$514M 0.1% 218
2019
Q3 		$942M Buy
5,598,356
+2,824,464
+102% +$460M 0.19% 117
2019
Q2 		$460M Sell
2,773,892
-947,019
-25% -$131M 0.09% 241
2019
Q1 		$545M Buy
3,720,911
+521,316
+16% +$75.6M 0.11% 199
2018
Q4 		$428M Sell
3,199,595
-1,116,921
-26% -$183M 0.1% 220
2018
Q3 		$822M Sell
4,316,516
-374,250
-8% -$68.8M 0.16% 137
2018
Q2 		$782M Sell
4,690,766
-1,165,345
-20% -$187M 0.16% 129
2018
Q1 		$986M Sell
5,856,111
-1,241,335
-17% -$208M 0.21% 106
2017
Q4 		$1.16B Sell
7,097,446
-870,071
-11% -$156M 0.24% 77
2017
Q3 		$1.63B Sell
7,967,517
-323,333
-4% -$75.2M 0.36% 50
2017
Q2 		$2.02B Buy
8,290,850
+1,253,802
+18% +$295M 0.46% 33
2017
Q1 		$1.68B Buy
7,037,048
+183,799
+3% +$42.8M 0.38% 46
2016
Q4 		$1.44B Sell
6,853,249
-274,733
-4% -$56.9M 0.35% 51
2016
Q3 		$1.64B Buy
7,127,982
+682,965
+11% +$167M 0.4% 41
2016
Q2 		$1.49B Sell
6,445,017
-48,974
-0.8% -$11.3M 0.37% 47
2016
Q1 		$1.74B Sell
6,493,991
-128,404
-2% -$36.8M 0.45% 36
2015
Q4 		$2.07B Buy
6,622,395
+1,073,317
+19% +$320M 0.52% 30
2015
Q3 		$1.51B Buy
5,549,078
+2,443,269
+79% +$751M 0.4% 45
2015
Q2 		$942M Buy
3,105,809
+254,466
+9% +$75.9M 0.22% 91
2015
Q1 		$849M Buy
2,851,343
+1,136,362
+66% +$324M 0.19% 109
2014
Q4 		$441M Buy
1,714,981
+94,126
+6% +$23.5M 0.1% 221
2014
Q3 		$391M Buy
1,620,855
+716,749
+79% +$160M 0.09% 246
2014
Q2 		$202M Sell
904,106
-377,604
-29% -$78.2M 0.05% 382
2014
Q1 		$264M Sell
1,281,710
-381,619
-23% -$75.6M 0.07% 293
2013
Q4 		$279M Sell
1,663,329
-7,470
-0.4% -$1.17M 0.08% 275
2013
Q3 		$241M Buy
1,670,799
+221,974
+15% +$29.6M 0.07% 289
2013
Q2 		$183M Buy
+1,448,825
New +$164M 0.06% 334

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

JP Morgan Chase's AGN Position: Q2 2020 in Review

JP Morgan Chase sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 3,705,099 shares — an estimated $656M sold.

JP Morgan Chase first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $2.07B in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • JP Morgan Chase reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • JP Morgan Chase sold 3,705,099 Allergan plc shares in Q2 2020, an estimated $656M.
  • JP Morgan Chase first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • JP Morgan Chase's Allergan plc position peaked at $2.07B in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.